Northern Ireland’s economy minister Nigel Dodds has opened The Warner Chilcott Centre of Excellence in Novel Oral Dosage Forms, a £5m drug delivery research facility in Larne.
The centre, the first facility of its type in Northern Ireland, will undertake research into innovative oral drug delivery technologies for the development of new and improved medicines.
The project is expected to create 14 new R&D graduate and post graduate research positions. It has been offered over £1.75m of support by RDA Invest Northern Ireland through its Centres of Excellence programme, with EU support under the NI Competitiveness Programme 2007-2013.
Dr Claire Gilligan, vice president, operations for the Larne Site said: ‘Dosage form development is an increasingly complex and technically challenging area within the global pharmaceutical industry. This specialised centre will significantly increase our R&D capabilities.’
Lee Cross, Warner Chilcott’s US senior vice president, technical operations added: ‘Warner Chilcott places great importance on its Larne facility. This new centre will complement our existing R&D activities and will enable us to develop new medicines with a competitive edge.’